These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4537361)

  • 1. [Supplemental studies on amphotericin B].
    Fukaya K
    Jpn J Antibiot; 1972 Feb; 25(1):17-20. PubMed ID: 4537361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Candida in feces following oral administration of premixed tetracycline and amphotericin B preparation].
    Fukaya K; Kitamoto O
    Kansenshogaku Zasshi; 1970 Jan; 43(10):283-8. PubMed ID: 4985501
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of amphotericin B on the fungal flora in feces.
    Bodey GP
    Clin Pharmacol Ther; 1969; 10(5):675-80. PubMed ID: 5817629
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effects of the administration of tetracycline-amphotericin B (Amphocycline) capsules on the growth of Candida in the feces].
    Watanabe K; Ikemoto H
    Jpn J Antibiot; 1969 Apr; 22(2):155-8. PubMed ID: 5306451
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of Candida albicans in infant oral materials and feces, and the sensitivity of amphotericin B to them].
    Hashimoto Y; Okuda K; Kametani H; Okumura S; Yonezawa W
    Shikwa Gakuho; 1972 Mar; 72(3):762-6. PubMed ID: 4556676
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 7. Candidemia caused by amphotericin B and fluconazole resistant Candida auris.
    Sarma S; Kumar N; Sharma S; Govil D; Ali T; Mehta Y; Rattan A
    Indian J Med Microbiol; 2013; 31(1):90-1. PubMed ID: 23508441
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EUCAST technical note on Amphotericin B.
    Lass-Flörl C; Arendrup MC; Rodriguez-Tudela JL; Cuenca-Estrella M; Donnelly P; Hope W;
    Clin Microbiol Infect; 2011 Dec; 17(12):E27-9. PubMed ID: 22011310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity of fungi in the genus Candida to antimicrobial preparations].
    Paliĭ GK; Ivanova SA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):218-20. PubMed ID: 2940962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.
    Montes LF; Cooper MD; Bradford LG; Lauderdale RO; Taylor CD
    Arch Dermatol; 1971 Jul; 104(1):45-56. PubMed ID: 5120161
    [No Abstract]   [Full Text] [Related]  

  • 13. [Minimum inhibitory concentration of amphotericin B in yeasts of medical interest].
    Fernández Andreu CM; González Miranda M; Illnait Zaragozí MT; Martínez Machín G
    Rev Cubana Med Trop; 1998; 50(1):48-53. PubMed ID: 9842268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-coated antifungal formulations for nebulisation.
    Albasarah YY; Somavarapu S; Stapleton P; Taylor KM
    J Pharm Pharmacol; 2010 Jul; 62(7):821-8. PubMed ID: 20636869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified agar diffusion assay for amphotericin B.
    Cosgrove RF; Jones GT
    J Pharm Pharmacol; 1978 May; 30(5):334-5. PubMed ID: 26759
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses.
    Hofstra W; de Vries-Hospers HG; van der Waaij D
    Infection; 1982; 10(4):223-7. PubMed ID: 7129644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of amphotericin B against Candida lusitaniae clinical isolates.
    Prigitano A; Biraghi E; Pozzi C; Viviani MA; Tortorano AM
    J Chemother; 2010 Feb; 22(1):71-2. PubMed ID: 20227999
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic effect of amphotericin B and tyrosol on biofilm formed by Candida krusei and Candida tropicalis from intrauterine device users.
    Shanmughapriya S; Sornakumari H; Lency A; Kavitha S; Natarajaseenivasan K
    Med Mycol; 2014 Nov; 52(8):853-61. PubMed ID: 25202127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.